Don’t miss out on the next big thing in the life sciences.
Big4Bio delivers curated news, insights, events, career opportunities, and updates from the industry's top regions to keep professionals informed and connected. Sign up now to stay in the know!

30K+ Subscribers
8 Key Regions
4 Focus Areas
Dr. John Yu, MD, CEO and Chairman, Kairos Pharma
Kairos's lead candidate, ENV-105, targets CD-105, a protein that drives cancer cells into a treatment-resistant state, and is currently advancing through a Phase 2 trial in prostate cancer and a Phase 1 trial in non-small cell lung cancer. In this Big4Bio CEO Q&A, Yu discusses the company's founding, the science behind its approach to drug resistance, recent milestones including its 2024 IPO and a new strategic collaboration with Bayer, and his outlook on the challenges facing biotech funding today.
Browse Our Regional Company Directories
Whether you're seeking potential partners, competitors, or new opportunities, these regional directories serve as a valuable resource for navigating the life sciences landscape.




